Literature DB >> 17041195

Benign schwannoma with perineurioma-like areas: A clinicopathologic study of 11 cases.

Dmitry V Kazakov1, Gaetano Magro, Andrey Yu Orlov, Ksenya V Shelekhova, Dmitry E Matsko, Dominic V Spagnolo, Michal Michal.   

Abstract

Eleven schwannomas are described. All tumors were well demarcated and surrounded by a true capsule or pseudocapsule and manifested Antoni A and Antoni B areas, Verocay bodies, and hyalinized vessels. In addition to typical schwannoma, there were clear cell areas composed of spindled cells arranged either in parallel sheets or in loops within the myxoid matrix, morphologically identical to retiform (reticular) perineurioma. The Schwann cells in the conventional schwannomatous areas displayed typical ultrastructural features. Those comprising the perineurioma-like areas revealed a primitive morphology. They were slender or polygonal and were devoid of an external lamina, pinocytic vesicles, or junctions. These findings suggest that the perineurioma-like areas consist of primitive or modified Schwann cells, or, alternatively, these perineurioma-like areas represent true, but incomplete perineurial differentiation within otherwise ordinary benign schwannomas. These neoplasms represent a morphologic variant of schwannoma having distinctive perineurial-like areas, a pattern which may elicit diagnostic difficulties.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17041195     DOI: 10.1177/1066896906293417

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  2 in total

1.  A soft tissue perineurioma and a hybrid tumor of perineurioma and schwannoma.

Authors:  Ji Young Park; Nam Jo Park; Sang Pyo Kim; Kun Young Kwon; Sang Sook Lee
Journal:  Korean J Pathol       Date:  2012-02-23

2.  Microcystic/reticular Schwannoma: morphological features causing diagnostic dilemma on fine-needle aspiration cytology.

Authors:  Shunyou Gong; Said Hafez-Khayyata; Wei Xin
Journal:  Am J Case Rep       Date:  2014-12-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.